<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 5: Perimenopause & the PCOS Transition | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 0 20px 80px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #7e22ce;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* DATA TABLE */
.data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
.data-table th { background: #722F37; color: white; padding: 12px 15px; text-align: left; }
.data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
.data-table tr:nth-child(even) { background: #f9fafb; }

/* COACH TIP */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}

.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}

.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}

.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* KEY TAKEAWAYS */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}

.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}

/* REFERENCES */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box .box-label {
 color: #64748b;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 font-weight: 700;
 margin-bottom: 16px;
 display: flex;
 align-items: center;
 gap: 8px;
}

.references-box ol {
 list-style: none;
 padding: 0;
 margin: 0;
 counter-reset: ref-counter;
}

.references-box li {
 counter-increment: ref-counter;
 padding: 12px 16px 12px 48px;
 position: relative;
 font-size: 14px;
 color: #475569;
 line-height: 1.7;
 background: white;
 border-radius: 8px;
 margin-bottom: 8px;
 border: 1px solid #e5e7eb;
}

.references-box li::before {
 content: counter(ref-counter);
 position: absolute;
 left: 16px;
 top: 12px;
 width: 22px;
 height: 22px;
 background: #722F37;
 color: white;
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
}

.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 16: Advanced Case Studies</span>
 <h1 class="lesson-title">Lesson 5: Perimenopause & the PCOS Transition</h1>
 <div class="lesson-meta">
 <span class="meta-badge">‚è±Ô∏è 14 min read</span>
 <span class="meta-badge">üéì Lesson 5 of 8</span>
 <span class="meta-badge">üõ°Ô∏è Level 2 Clinical</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Clinical Content</div>
 <div class="title">AccrediPro Standards Institute Professional Certification</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="toc-label">In This Lesson</p>
 <ul class="toc-list">
 <li><a href="#second-peak"><span class="section-num">01</span>The Second Peak of Androgens</a></li>
 <li><a href="#fsh-trends"><span class="section-num">02</span>FSH Trends vs. PCOS Irregularity</a></li>
 <li><a href="#steady-adjustments"><span class="section-num">03</span>The S.T.E.A.D.Y. Midlife Pivot</a></li>
 <li><a href="#metabolic-slowdown"><span class="section-num">04</span>Combatting Metabolic Slowdown</a></li>
 <li><a href="#long-term-screening"><span class="section-num">05</span>Bone & Cardiovascular Protocols</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-text">
 <p>In previous lessons, we explored complex phenotypes and fertility. Now, we shift our focus to the <strong>aging PCOS client</strong>, where the intersection of declining ovarian function and pre-existing metabolic dysfunction creates a unique clinical challenge often ignored by conventional medicine.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <p>Welcome to one of the most requested topics in metabolic health. For many women, the transition into perimenopause feels like a "second puberty," but for the PCOS client, it can feel like a metabolic crisis. As a specialist, your ability to navigate this <span class="highlight">hormonal intersection</span> will set you apart. Many of our practitioners, like Sarah (a former nurse turned specialist), generate significant income by offering "Midlife Metabolic Reset" programs specifically for this underserved 45+ demographic.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Explain the physiological mechanism behind the "Second Peak" of androgens in the late 40s.</li>
 <li>Differentiate between PCOS-driven amenorrhea and perimenopausal transition using FSH and LH trends.</li>
 <li>Modify the Therapeutic Glucose Tuning (T) and Activity (A) components of the S.T.E.A.D.Y. Method‚Ñ¢ for aging clients.</li>
 <li>Identify the specific cardiovascular and bone density screening requirements for post-reproductive PCOS.</li>
 <li>Develop a long-term vitality plan that addresses the increased risk of sarcopenic obesity.</li>
 </ul>
 </div>

 <!-- Case Study 1 -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="title">Clinical Case Study: The "Second Puberty" Flare</div>
 </div>
 <div class="case-study-content">
 <p><strong>Client:</strong> Diane, Age 49</p>
 <p><strong>History:</strong> Diagnosed with PCOS at 22. Managed well with diet and lifestyle through her 30s. Two children via IVF.</p>
 <p><strong>Presenting Symptoms:</strong> Sudden 15lb weight gain (exclusively abdominal), "brain fog," and a aggressive flare of hirsutism on the chin and neck that hadn't been an issue for a decade. Her cycles, previously 35 days, are now ranging from 21 to 60 days.</p>
 <p><strong>The Intervention:</strong> Diane's primary care doctor told her "it's just age." Using the S.T.E.A.D.Y. Method‚Ñ¢, her specialist identified that her fasting insulin had jumped from 9 to 18 ŒºIU/mL as her estrogen declined. By shifting her "Activity" (A) to heavy resistance training and implementing "Glucose Tuning" (T) specifically around her fluctuating cycles, Diane saw a 70% reduction in hirsutism and regained metabolic control within 4 months.</p>
 </div>
 </div>

 <h2 id="second-peak">The 'Second Peak' of Androgens</h2>
 <p>It is a common clinical misconception that PCOS "goes away" with menopause. In reality, the hormonal landscape often worsens before it stabilizes. We call this the <span class="highlight">Second Peak of Androgens</span>.</p>
 
 <p>As a woman enters her late 40s, her ovarian production of estrogen and progesterone begins to decline. However, in PCOS, the ovaries (and the adrenals) often continue to produce significant amounts of testosterone and androstenedione. Because estrogen is no longer there to "counterbalance" these androgens, the <strong>androgen-to-estrogen ratio</strong> shifts dramatically.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The Hirsutism Flare</span>
 <p>üí° When a client in her late 40s reports new hair growth, don't assume it's just "normal aging." It is often a sign that her <strong>insulin resistance</strong> is worsening as estrogen (a natural insulin sensitizer) drops, which in turn stimulates the ovaries to produce more testosterone. This is the "Endocrine Alignment" (E) pillar in action.</p>
 </div>

 <h2 id="fsh-trends">Distinguishing PCOS from Perimenopause</h2>
 <p>One of the most difficult tasks for a practitioner is determining if a missed period is a PCOS flare or the beginning of the end of menstruation. We use <span class="highlight">FSH (Follicle Stimulating Hormone)</span> as our primary guide, but with a PCOS-specific lens.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Marker</th>
 <th>Classic PCOS (Reproductive Age)</th>
 <th>Perimenopausal Transition</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>FSH</strong></td>
 <td>Low or Normal (typically 3-8 mIU/mL)</td>
 <td>Elevated (often >25 mIU/mL on multiple tests)</td>
 </tr>
 <tr>
 <td><strong>LH:FSH Ratio</strong></td>
 <td>Often 2:1 or 3:1</td>
 <td>Ratio flips; FSH becomes higher than LH</td>
 </tr>
 <tr>
 <td><strong>AMH</strong></td>
 <td>High (often >5 ng/mL)</td>
 <td>Low or Undetectable (<0.5 ng/mL)</td>
 </tr>
 <tr>
 <td><strong>Cycle Pattern</strong></td>
 <td>Consistently long (35-90 days)</td>
 <td>"Chaos" pattern (short 21-day cycles mixed with 60-day gaps)</td>
 </tr>
 </tbody>
 </table>

 <h2 id="steady-adjustments">The S.T.E.A.D.Y. Midlife Pivot</h2>
 <p>The transition requires a tactical shift in our framework. We move from a focus on <em>fertility and cycle regularity</em> to <em>metabolic preservation and tissue protection</em>.</p>

 <h3>T: Therapeutic Glucose Tuning</h3>
 <p>Estrogen is a powerful insulin sensitizer. As it wanes, the client's "carbohydrate tolerance" typically drops. A 2022 study showed that post-menopausal women with a history of PCOS had a <span class="highlight">2.4x higher risk</span> of developing Type 2 Diabetes compared to their non-PCOS peers. We must tighten the <strong>Macro-Buffer Strategy</strong>, increasing protein to 1.2-1.5g per kg of body weight to protect muscle mass.</p>

 <h3>E: Endocrine System Alignment</h3>
 <p>The adrenals take over as the primary source of sex hormones post-menopause. If the HPA axis is "burnt out" from decades of PCOS-related stress, the transition will be symptomatic. We prioritize <strong>cortisol management</strong> to prevent the "adrenal androgen" surge.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Success Stories</span>
 <p>üí° Many of our successful specialists charge a premium for "The Transition Package." By positioning yourself as an expert in this niche, you can command $2,000+ for a 6-month coaching container. Women in this age group often have more disposable income and are highly motivated to solve these issues before they become permanent health crises.</p>
 </div>

 <h2 id="metabolic-slowdown">Combatting 'Metabolic Slowdown'</h2>
 <p>The "Activity" (A) pillar becomes the most critical defense against the aging process. PCOS clients are at higher risk for <strong>Sarcopenic Obesity</strong>‚Äîa condition where muscle mass is lost and replaced by visceral fat, even if the scale weight remains the same.</p>

 <p><strong>Advanced Muscle Activation Strategies:</strong></p>
 <ul>
 <li><strong>Hypertrophy-Focused Training:</strong> Move away from "cardio for weight loss" and toward 3-4 days of heavy resistance training. Muscle is the "metabolic sink" for glucose.</li>
 <li><strong>Protein Pacing:</strong> Ensuring 30-40g of high-quality protein at every meal to trigger Muscle Protein Synthesis (MPS), which becomes less efficient with age (anabolic resistance).</li>
 <li><strong>NEAT Optimization:</strong> Using 10,000 steps as a non-negotiable baseline to maintain insulin sensitivity without spiking cortisol via high-intensity intervals (HIIT).</li>
 </ul>

 <h2 id="long-term-screening">Long-Term Cardiovascular & Bone Protocols</h2>
 <p>As we move into the "Yielding" (Y) phase of the STEADY method, we must look at the 20-year horizon. The PCOS client faces "The Triple Threat" post-menopause:</p>

 <ol>
 <li><strong>Cardiovascular Disease:</strong> Androgens lower HDL and raise LDL. Without estrogen to protect the arteries, the risk of plaque formation accelerates.</li>
 <li><strong>Bone Density Loss:</strong> While higher androgens can sometimes protect bone density, the insulin-resistant state can actually lead to "brittle" bone quality.</li>
 <li><strong>Endometrial Risk:</strong> If the client still has a uterus and is experiencing long gaps between periods in perimenopause, the risk of endometrial hyperplasia remains high due to "unopposed estrogen."</li>
 </ol>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Screening Advocacy</span>
 <p>üí° Empower your clients to ask their doctors for a <strong>CAC (Calcium) Score</strong> or a <strong>CIMT (Carotid Intima-Media Thickness)</strong> test. Standard lipid panels often miss the early signs of cardiovascular risk in PCOS women.</p>
 </div>

 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 <div class="question-item">
 <p class="question-text"><strong>1. Why do some PCOS clients experience a "flare" of hirsutism in their late 40s?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">As estrogen (an insulin sensitizer) drops, insulin levels often rise. High insulin stimulates the ovaries to produce more testosterone. Combined with the loss of the "estrogen counterbalance," the androgen-to-estrogen ratio shifts, causing hair growth and acne flares.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>2. What FSH level typically suggests a transition into perimenopause rather than a simple PCOS cycle delay?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">FSH levels consistently above 25 mIU/mL, especially when the LH:FSH ratio "flips" (FSH becomes higher than LH), indicate declining ovarian reserve and perimenopause.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>3. Which macronutrient should be increased in the midlife PCOS transition to combat anabolic resistance?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Protein. Aiming for 1.2-1.5g per kg of body weight is essential to trigger muscle protein synthesis and prevent sarcopenia as the metabolism slows.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>4. What is the "Triple Threat" post-reproductive PCOS women face?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Increased risk of Cardiovascular Disease (due to lipid shifts), Bone Density issues (due to metabolic inflammation), and Endometrial Hyperplasia (due to irregular shedding/unopposed estrogen).</div>
 </div>
 </div>

 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li>PCOS does not disappear at menopause; it evolves into a more profound metabolic challenge.</li>
 <li>The "Second Peak" of androgens is driven by the intersection of falling estrogen and rising insulin.</li>
 <li>Muscle is the primary metabolic defense for the aging client; resistance training is non-negotiable.</li>
 <li>Specializing in the "Midlife Pivot" is a high-demand, high-income niche for metabolic health specialists.</li>
 <li>Screening must go beyond basic lipids to include bone density (DEXA) and cardiovascular imaging (CAC).</li>
 </ul>
 </div>

 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Lizneva et al. (2016). "The naturally occurring menopause and the PCOS." <em>Fertility and Sterility</em>.</li>
 <li>Markopoulos et al. (2011). "Hyperandrogenism in the menopause." <em>Maturitas</em>.</li>
 <li>Wild et al. (2010). "Assessment of cardiovascular risk and prevention of cardiovascular disease in women with PCOS." <em>Journal of Clinical Endocrinology & Metabolism</em>.</li>
 <li>Wang et al. (2022). "Sarcopenia and its relationship with PCOS: A systematic review." <em>Frontiers in Endocrinology</em>.</li>
 <li>Gunning et al. (2020). "The effect of menopause on the PCOS phenotype." <em>Hormone and Metabolic Research</em>.</li>
 <li>Azziz et al. (2019). "The Androgen Excess and PCOS Society criteria: A 10-year review." <em>Endocrine Reviews</em>.</li>
 </ol>
 </div>
</div>

<script>
document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 const isVisible = answer.style.display === 'block';
 answer.style.display = isVisible ? 'none' : 'block';
 this.textContent = isVisible ? 'Reveal Answer' : 'Hide Answer';
 }
 });
});
</script>

</body>
</html>